团体心理治疗对慢性精神分裂症患者认知功能的影响
|
摘要
目的 :探讨团体心理治疗对慢性精神分裂症患者认知功能的影响。方法 :将2017年2月至2018年11月在江西康宁医院接受治疗的80例慢性精神分裂症患者按照治疗方案不同分为观察组40例和对照组40例。观察组中男性26例,女性14例,年龄为36～64岁,平均年龄为(41.58±7.69)岁;对照组中男性25例,女性15例,年龄为35～63岁,平均年龄为(42.66±7.14)岁。对照组患者接受常规治疗,观察组患者在对照组的治疗基础上接受团体心理治疗。观察两组治疗前后蒙特利尔认知评估量表(MoCA)、简易智力状态量表(MMSE)、社会功能评定量表(SSSI)、自尊量表(SES)、自我和谐量表(SCCS)的评分情况。结果 :观察组干预后的MoCA、MMSE、SES评分均高于干预前和对照组(P <0.05),SSSI、SCCS评分低于干预前和对照组(P <0.05)。结论:团体治疗后,患者的认知功能、精神状态、社会功能、自尊心理、自我和谐等情况均得到了明显改善,提示团体心理治疗对慢性精神分裂症患者的认知功能有积极影响。
Objective: To explore the effect of group psychotherapy on cognitive function in patients with chronic schizophrenia. Methods: Eighty patients with chronic schizophrenia who were treated at Kangning Hospital in Jiangxi from February 2017 to November 2018 were divided into an observation group with 40 cases and a control group with 40 cases according to different treatment options. There were 26 males and 14 females in the observation group, and the age ranged from36 to 64 years, with an average age of(41.58 ± 7.69) years; there were 25 males and 15 females in the control group, and the age ranged from 35 to 63 years, with an average age of(42.66 ± 7.14) years. Patients in the control group received routine treatment,and the patients in the observation group received group psychotherapy on the basis of the treatment in the control group. The scores of the Montreal cognitive assessment scale(MoCA), the mini-mental state examination scale(MMSE), the social function assessment scale(SSSI), the self-esteem scale(SES), and the self consistency and congruence scale(SCCS) were observed before and after treatment. Results: The scores of MoCA, MMSE and SES in the observation group after intervention were higher than those before intervention and in the control group(P < 0.05), the scores of SSSI and SCCS in the observation group were lower than those before intervention and in the control group. Conclusion: After group therapy, the cognitive function, mental state, social function, self-esteem and self-harmony of the patients have been significantly improved, and it suggests that group psychotherapy has a positive effect on cognitive function of patients with chronic schizophrenia.
Objective: To explore the effect of group psychotherapy on cognitive function in patients with chronic schizophrenia. Methods: Eighty patients with chronic schizophrenia who were treated at Kangning Hospital in Jiangxi from February 2017 to November 2018 were divided into an observation group with 40 cases and a control group with 40 cases according to different treatment options. There were 26 males and 14 females in the observation group, and the age ranged from36 to 64 years, with an average age of(41.58 ± 7.69) years; there were 25 males and 15 females in the control group, and the age ranged from 35 to 63 years, with an average age of(42.66 ± 7.14) years. Patients in the control group received routine treatment,and the patients in the observation group received group psychotherapy on the basis of the treatment in the control group. The scores of the Montreal cognitive assessment scale(MoCA), the mini-mental state examination scale(MMSE), the social function assessment scale(SSSI), the self-esteem scale(SES), and the self consistency and congruence scale(SCCS) were observed before and after treatment. Results: The scores of MoCA, MMSE and SES in the observation group after intervention were higher than those before intervention and in the control group(P < 0.05), the scores of SSSI and SCCS in the observation group were lower than those before intervention and in the control group. Conclusion: After group therapy, the cognitive function, mental state, social function, self-esteem and self-harmony of the patients have been significantly improved, and it suggests that group psychotherapy has a positive effect on cognitive function of patients with chronic schizophrenia.
引文
[1]郎芳,王唯平,张增国,等.精神分裂症阴性症状的非药物治疗进展[J].广东医学,2018,39(S2):278-280,284.
[2]Martín JC,Acu?a MJ,Labrador J,et al.Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics:not only prolactin[J].Actas Esp Psiquiatr,2018,46(6):217-225.
[3]Sch?ttle D,Janetzky W,Luedecke D,et al.Correction to:Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole:a 6-month,real-life non-interventional study[J].BMC Psychiatry,2018,18(1):389.
[4]伍淑芳,邹荣海,伍亮凤,等.住院精神分裂症患者亲属心理状况及心理健康教育需求研究[J].中国当代医药,2018,25(6):191-193,196.
[5]毛红岩,陈长浩.氨磺必利联合团体心理治疗对首发男性精神分裂症疗效及依从性的影响[J].精神医学杂志,2017,30(6):442-445.
[6]傅育敏.团体心理治疗对康复期精神分裂症患者临床效果的影响[J].实用临床护理学电子杂志,2017,2(45):122,134.
[7]章三斌,雷海英,王芳.团体心理干预应用于精神分裂症康复期患者对其疾病控制及社会功能的影响[J].当代医学,2017,23(27):129-130.
[8]林春元,李玉梅.团体认知行为疗法在精神分裂症康复期患者的实施观察[J].中国医学创新,2017,14(5):137-141.
[9]关涛,杨丹,韩鹏.奥氮平合并团体治疗对偏执型精神分裂症的影响[J].中国现代医生,2016,54(15):58-61.
[10]孟庆玲.影响精神分裂症患者恢复社会功能的相关干扰因素[J].当代护士(下旬刊),2018,25(6):127-130.
[11]刘晓亲,龚定宏.社区慢性精神分裂症患者家庭照护者认知团体心理治疗的近期与远期干预效果研究[J].中国全科医学,2018,21(7):867-873.
[2]Martín JC,Acu?a MJ,Labrador J,et al.Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics:not only prolactin[J].Actas Esp Psiquiatr,2018,46(6):217-225.
[3]Sch?ttle D,Janetzky W,Luedecke D,et al.Correction to:Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole:a 6-month,real-life non-interventional study[J].BMC Psychiatry,2018,18(1):389.
[4]伍淑芳,邹荣海,伍亮凤,等.住院精神分裂症患者亲属心理状况及心理健康教育需求研究[J].中国当代医药,2018,25(6):191-193,196.
[5]毛红岩,陈长浩.氨磺必利联合团体心理治疗对首发男性精神分裂症疗效及依从性的影响[J].精神医学杂志,2017,30(6):442-445.
[6]傅育敏.团体心理治疗对康复期精神分裂症患者临床效果的影响[J].实用临床护理学电子杂志,2017,2(45):122,134.
[7]章三斌,雷海英,王芳.团体心理干预应用于精神分裂症康复期患者对其疾病控制及社会功能的影响[J].当代医学,2017,23(27):129-130.
[8]林春元,李玉梅.团体认知行为疗法在精神分裂症康复期患者的实施观察[J].中国医学创新,2017,14(5):137-141.
[9]关涛,杨丹,韩鹏.奥氮平合并团体治疗对偏执型精神分裂症的影响[J].中国现代医生,2016,54(15):58-61.
[10]孟庆玲.影响精神分裂症患者恢复社会功能的相关干扰因素[J].当代护士(下旬刊),2018,25(6):127-130.
[11]刘晓亲,龚定宏.社区慢性精神分裂症患者家庭照护者认知团体心理治疗的近期与远期干预效果研究[J].中国全科医学,2018,21(7):867-873.